Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Crinetics Pharmaceuticals, Inc. (CRNX) had Pre-Tax Profit Margin of -28675.46% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.04M |
|
$-298.41M |
|
-- |
|
$1.04M |
|
$339.89M |
|
$-338.85M |
|
$40.92M |
|
$-297.94M |
|
$-297.94M |
|
$-297.94M |
|
$-298.41M |
|
$-298.41M |
|
$-297.94M |
|
$-338.85M |
|
$-351.00M |
|
80.78M |
|
80.78M |
|
$-3.69 |
|
$-3.69 |
|
| Balance Sheet Financials | |
$1.38B |
|
$12.07M |
|
$59.20M |
|
$1.43B |
|
$59.68M |
|
-- |
|
$50.10M |
|
$109.79M |
|
$1.32B |
|
$1.32B |
|
$1.32B |
|
92.93M |
|
| Cash Flow Statement Financials | |
$-225.97M |
|
$-574.82M |
|
$1.01B |
|
$56.20M |
|
$265.85M |
|
$209.65M |
|
$69.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-32613.47% |
|
-32613.47% |
|
-33782.48% |
|
|
Pre-Tax Profit Margin |
-28675.46% |
-28720.69% |
|
$-229.81M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-22.52% |
|
-22.52% |
|
-20.80% |
|
-22.52% |
|
$14.26 |
|
$-2.84 |
|
$-2.80 |
|